Home > Insider Trading > Filing (0001437749-19-024141)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
946486	Windtree Therapeutics Inc	WINT	Biological Products, (No Disgnostic Substances) (2836)	943171943

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1573160	James Huang	C/O Windtree Therapeutics, Inc. 2600 Kelly Road, Suite 100 Warrington PA 18976		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-12-06	1,655,629	$3.02	6,182,974	No	4	P	Indirect	Via Panacea Venture Healthcare Fund I L.P.
Common Stock	Acquisiton	2019-12-06	96,429	$0.00	210,844	No	4	A	Indirect	Via Rui Jin (HK) Consulting Management Company Limited

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Via Panacea Venture Healthcare Fund I L.P.
No	4	A	Indirect	Via Rui Jin (HK) Consulting Management Company Limited

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series I Warrants	Acquisiton	2019-12-06	827,815	$0.00	827,815	$4.03

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
827,815	2020-06-06	2024-12-06	No	4	P	Indirect

Footnotes

The Reporting Person is Director of Panacea Venture Healthcare Fund GP I L.P. The Reporting Person disclaims beneficial ownership of the shares held by Panacea Venture Healthcare Fund I L.P., except to the extent of his pecuniary interest therein.
Issued in connection with a Placement Agency Agreement for the Company's offering of common stock and warrants on December 6, 2019. The Reporting Person is a Director of Rui Jin (HK) Consulting Management Company Limited.
Issued in connection with the purchase of shares of common stock on December 6, 2019 as reported above.